Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aptorum Group Ltd (APM)
NASDAQ:APM
Holding APM?
Track your performance easily
APM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.46 - $17.49
Previous CloseN/A
Volume172.64K
Average Volume (3M)4.73M
Market Cap
$9.22M
Enterprise Value$16.51M
Total Cash (Recent Filing)$18.22M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)69.0
Beta-0.12
Next Earnings
Apr 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding5,346,823
10 Day Avg. Volume184,149
30 Day Avg. Volume4,726,658
Standard Deviation0.79
R-Squared0.00066
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.02
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.79
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.56
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aptorum Group News
PremiumCompany Announcements
Aptorum Group to Issue 1.5 Million Class A Shares
PremiumMarket News
3 Penny Stocks to Watch Now, 01/02/25
PremiumCompany Announcements
Aptorum Group Reports Reduced Net Loss in Mid-2024 Financials
PremiumCompany Announcements
Aptorum Group Announces Shareholder Approval on Key Proposals
PremiumCompany Announcements
Aptorum Group Announces Key Shareholder Meeting
PremiumCompany Announcements
Aptorum Group Board Sees Key Resignations
PremiumCompany Announcements
Aptorum Group Appoints New Finance HeadOwnership Overview
―
Insiders
0.05% Mutual Funds
0.26% Other Institutional Investors
98.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
APM FAQ
What was Aptorum Group Ltd’s price range in the past 12 months?
Aptorum Group Ltd lowest stock price was $0.46 and its highest was $17.49 in the past 12 months.
What is Aptorum Group Ltd’s market cap?
Aptorum Group Ltd’s market cap is $9.22M.
When is Aptorum Group Ltd’s upcoming earnings report date?
Aptorum Group Ltd’s upcoming earnings report date is Apr 21, 2025 which is in 79 days.
How were Aptorum Group Ltd’s earnings last quarter?
Aptorum Group Ltd released its earnings results on Dec 20, 2024. The company reported -$0.5 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.5.
Is Aptorum Group Ltd overvalued?
According to Wall Street analysts Aptorum Group Ltd’s price is currently Overvalued.
Does Aptorum Group Ltd pay dividends?
Aptorum Group Ltd does not currently pay dividends.
What is Aptorum Group Ltd’s EPS estimate?
Aptorum Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aptorum Group Ltd have?
Aptorum Group Ltd has 5,346,823 shares outstanding.
What happened to Aptorum Group Ltd’s price movement after its last earnings report?
Aptorum Group Ltd reported an EPS of -$0.5 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.351%.
Which hedge fund is a major shareholder of Aptorum Group Ltd?
Currently, no hedge funds are holding shares in APM
---
Company Description
Aptorum Group Ltd
Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.
---
Technical Analysis
Arrowhead Pharmaceuticals
―
BioMarin Pharmaceutical
―
Neurocrine
―
Vertex Pharmaceuticals
―
Sarepta Therapeutics
―
---